Pharmacology

Action Mechanism of Action Reference
AGONIST Luteinizing hormone/Choriogonadotropin receptor agonist PubMed FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Infertility 3 D007246 ClinicalTrials
Hypogonadism 2 D007006 ClinicalTrials
Infertility, Female 1 D007247 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
22.22
Vascular disorders
17.78
Pregnancy, puerperium and perinatal conditions
11.11
Reproductive system and breast disorders
11.11
Endocrine disorders
8.89
Metabolism and nutrition disorders
6.67
Eye disorders
4.44
Immune system disorders
4.44
Cardiac disorders
2.22
Congenital, familial and genetic disorders
2.22
Hepatobiliary disorders
2.22
Injury, poisoning and procedural complications
2.22
Investigations
2.22
Respiratory, thoracic and mediastinal disorders
2.22

Cross References

Resources Reference
CAS NUMBER 152923-57-4
ChEMBL CHEMBL1201419
FDA SRS 3JGY52XJNA